Part I General Information on Cancer Staging and End-Results
Reporting.- 1. Principles of Cancer Staging.- . Organization
of the AJCC Cancer Staging Manual.- 3. Cancer Survival Analysis.-
4. Risk Models for Individualized Prognosis in the Practice of
Precision Oncology.- Part II Head and Neck.- 5. Staging Head and
Neck Cancers.- 6. Cervical Lymph Nodes and Unknown Primary Tumors
of the Head and Neck.- 7. Lip and Oral Cavity.- 8. Major Salivary
Glands.- 9. Nasopharynx.- 10. HPV-Mediated (p16+) Oropharyngeal
Cancer.- 11. Oropharynx (p16−) and Hypopharynx.- 12. Nasal Cavity
and Paranasal Sinuses.- 13. Larynx.- 14. Mucosal Melanoma of the
Head and Neck.- 15. Cutaneous Squamous Cell Carcinoma of the Head
and Neck.- Part III Upper Gastrointestinal Tract.- 16. Esophagus
and Esophagogastric Junction.- 17. Stomach.- 18. Small Intestine.-
Part IV Lower Gastrointestinal Tract.- 19. Appendix – Carcinoma.-
20. Colon and Rectum.- 21. Anus.- Part V Hepatobiliary System.- 22.
Liver.- 23. Intrahepatic Bile Ducts.- 24. Gallbladder.- 25.
Perihilar Bile Ducts.- 26. Distal Bile Duct.- 27. Ampulla of
Vater.- 28. Pancreas – Exocrine.- Part VI Neuroendocrine Tumors.-
29. Neuroendocrine Tumors of the Stomach.- 30. Neuroendocrine
Tumors of the Duodenum and Ampulla of Vater.- 31. Neuroendocrine
Tumors of the Jejunum and Ileum.- 32. Neuroendocrine Tumors of the
Appendix.- 33. Neuroendocrine Tumors of the Colon and Rectum.- 34.
Neuroendocrine Tumors of the Pancreas.- Part VII Thorax.- 35.
Thymus.- 36. Lung.- 37. Malignant Pleural Mesothelioma.- Part
VIII.- Bone.- 38. Bone (appendicular skeleton, spine, and pelvis).-
Part IX Soft Tissue Sarcoma.- 39. Introduction.- 40. Soft Tissue
Sarcoma of the Head and Neck.- 41. Soft Tissue Sarcoma of the Trunk
and Extremities.- 42. Soft Tissue Sarcoma of the Abdomen and
Thoracic Visceral Organs.- 43. Gastrointestinal Stromal Tumor.- 44.
Soft Tissue Sarcoma of the Retroperitoneum.- 45. Soft Tissue
Sarcoma – Unusual Histologies and Sites.- Part X Skin.- 46. Merkel
Cell Carcinoma.- 47. Melanoma of the Skin.- Part XI Breast.-
48. Breast.- Part XII Female Reproductive Organs.- 49.
Introduction.- 50. Vulva.- 51. Vagina.- 52. Cervix Uteri.- 53.
Corpus Uteri – Carcinoma and Carcinosarcoma.- 54. Corpus Uteri –
Sarcoma.- 55. Ovary, Fallopian Tube, and Primary Peritoneal
Carcinoma.- 56. Gestational Trophoblastic Neoplasms.- Part
XIII Male Genital Organs.- 57. Penis.- 58. Prostate.- 59. Testis.-
Part XIV Urinary Tract.- 60. Kidney.- 61. Renal Pelvis and Ureter.-
62. Urinary Bladder.- 63. Urethra.- Part XV Ophthalmic Sites.- 64.
Eyelid Carcinoma.- 65. Conjunctival Carcinoma.- 66. Conjunctival
Melanoma.- 67. Uveal Melanoma.- 68. Retinoblastoma.- 69. Lacrimal
Gland Carcinoma.- 70. Orbital Sarcoma.- 71. Ocular Adnexal
Lymphoma.- Part XVI Central Nervous System.- 72. Brain and Spinal
Cord.- Part XVII Endocrine System.- 73. Thyroid – Differentiated
and Anaplastic Carcinoma.- 74. Thyroid – Medullary Carcinoma.- 75.
Parathyroid.- 76.Adrenal Cortical Carcinoma.- 77. Adrenal –
Neuroendocrine Tumors.- Part XVIII Hematologic Malignancies.- 78.
Introduction.- 79. Hodgkin and Non-Hodgkin Lymphomas.- 80.
Pediatric Hodgkin and Non-Hodgkin Lymphomas.- 81. Primary Cutaneous
Lymphomas.- 82. Multiple Myeloma and Plasma Cell Disorders.- 83.
Leukemia.- Part XIX Additional Contributors.- Index.
The American Joint Committee on Cancer (AJCC) was established in 1959 to formulate and publish systems of classification of cancer, including staging and end-results reporting, that will be acceptable to and used by the medical profession for selecting the most effective treatment, determining prognosis, and continuing evaluation of cancer control measures. The AJCC is composed of 18 member organizations, and its activities are administered by the Chicago-based American College of Surgeons.
“This is the most recent update of a manual for the staging of adult cancers from the American Joint Committee on Cancer. … This is a valuable reference for students, physicians, scientists, and cancer registrars. With clear descriptions and definitions of terminology, it can be used by experienced practitioners as well as those new to cancer staging. … Overall, this edition is a welcome update, incorporating new advances in cancer knowledge to more accurately reflect modern cancer care.” (Emily L. Albright, Doody's Book Reviews, February, 2017)
Ask a Question About this Product More... |